Chicago Partners Investment Group’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Buy
52,653
+12,064
+30% +$38.6K ﹤0.01% 1352
2025
Q4
$107K Buy
40,589
+9
+0% +$21 ﹤0.01% 1263
2025
Q3
$88.9K Sell
40,580
-409
-1% -$966 ﹤0.01% 1190
2025
Q2
$163K Buy
40,989
+363
+0.9% +$903 ﹤0.01% 1052
2025
Q1
$127K Buy
40,626
+20,067
+98% +$103K ﹤0.01% 892
2024
Q4
$147K Hold
20,559
﹤0.01% 825
2024
Q3
$202K Hold
20,559
0.01% 763
2024
Q2
$184K Hold
20,559
0.01% 719
2024
Q1
$244K Hold
20,559
0.01% 630
2023
Q4
$157K Buy
20,559
+2,688
+15% +$14.1K 0.01% 672
2023
Q3
$61.7K Buy
17,871
+5,000
+39% +$32.6K ﹤0.01% 637
2023
Q2
$92.4K Hold
12,871
﹤0.01% 660
2023
Q1
$73.4K Hold
12,871
﹤0.01% 646
2022
Q4
$106K Hold
12,871
0.01% 618
2022
Q3
$106K Buy
12,871
+2,000
+18% +$23.1K 0.01% 561
2022
Q2
$127K Buy
+10,871
New +$142K 0.01% 563

Other funds holding IOVA